Search research articles
Contact Us
Filters
Showing results (411-420 of 645) with videos related to
Page
of 65
Sort By:
The Journal of Pharmacology and Experimental Therapeutics
|
June 15, 2013
Effect of the mixed phosphodiesterase 3/4 inhibitor RPL554 on human isolated bronchial smooth muscle tone
Luigino Calzetta, Clive P Page, Domenico Spina, et al.
Chest
|
October 21, 2005
Pharmacodynamics of levofloxacin in patients with acute exacerbation of chronic bronchitis
Mario Cazzola, Maria Gabriella Matera, Giovanna Donnarumma, et al.
Respiratory Medicine
|
October 6, 2009
Metabolic syndrome and risk of pulmonary involvement
Paola Rogliani, Giacomo Curradi, Marco Mura, et al.
European Journal of Pharmacology
|
December 3, 2014
Pharmacological characterization of the interaction between aclidinium bromide and formoterol fumarate on human isolated bronchi
Mario Cazzola, Luigino Calzetta, Clive P Page, et al.
Drugs
|
October 20, 2022
Inhaled Corticosteroids in Adults with Non-cystic Fibrosis Bronchiectasis: From Bench to Bedside. A Narrative Review
Miguel Ángel Martínez-García, Grace Oscullo, Alberto García-Ortega, et al.
Pulmonary Pharmacology & Therapeutics
|
June 15, 2021
Ceiling effect of beclomethasone/formoterol/glycopyrronium triple fixed-dose combination in COPD: A translational bench-to-bedside study
Paola Rogliani, Josuel Ora, Andrea Girolami, et al.
Leukemia Research
|
May 2, 2017
Recommendations for molecular testing in classical Ph1-neg myeloproliferative disorders-A consensus project of the Italian Society of Hematology
Paola Guglielmelli, Daniela Pietra, Fabrizio Pane, et al.
Pulmonary Pharmacology & Therapeutics
|
September 15, 2019
Efficacy and cardiovascular safety profile of dual bronchodilation therapy in chronic obstructive pulmonary disease: A bidimensional comparative analysis across fixed-dose combinations
Paola Rogliani, Maria Gabriella Matera, Beatrice Ludovica Ritondo, et al.
Pulmonary Pharmacology & Therapeutics
|
May 5, 2004
Salmeterol/fluticasone propionate in a Single Inhaler Device versus theophylline+fluticasone propionate in patients with COPD
Mario Cazzola, Paolo Noschese, Stefano Centanni, et al.
Respiratory Medicine
|
August 9, 2008
It's about time--directing our attention toward modifying the course of COPD
Mario Cazzola, Nicola A Hanania, Paul W Jones, et al.
Page
of 65
Search research articles
Search
Showing results (411-420 of 645) with videos related to
Sort By:
Page
of 65
The Journal of Pharmacology and Experimental Therapeutics
|
June 15, 2013
Effect of the mixed phosphodiesterase 3/4 inhibitor RPL554 on human isolated bronchial smooth muscle tone
Luigino Calzetta, Clive P Page, Domenico Spina, et al.
Chest
|
October 21, 2005
Pharmacodynamics of levofloxacin in patients with acute exacerbation of chronic bronchitis
Mario Cazzola, Maria Gabriella Matera, Giovanna Donnarumma, et al.
Respiratory Medicine
|
October 6, 2009
Metabolic syndrome and risk of pulmonary involvement
Paola Rogliani, Giacomo Curradi, Marco Mura, et al.
European Journal of Pharmacology
|
December 3, 2014
Pharmacological characterization of the interaction between aclidinium bromide and formoterol fumarate on human isolated bronchi
Mario Cazzola, Luigino Calzetta, Clive P Page, et al.
Drugs
|
October 20, 2022
Inhaled Corticosteroids in Adults with Non-cystic Fibrosis Bronchiectasis: From Bench to Bedside. A Narrative Review
Miguel Ángel Martínez-García, Grace Oscullo, Alberto García-Ortega, et al.
Pulmonary Pharmacology & Therapeutics
|
June 15, 2021
Ceiling effect of beclomethasone/formoterol/glycopyrronium triple fixed-dose combination in COPD: A translational bench-to-bedside study
Paola Rogliani, Josuel Ora, Andrea Girolami, et al.
Leukemia Research
|
May 2, 2017
Recommendations for molecular testing in classical Ph1-neg myeloproliferative disorders-A consensus project of the Italian Society of Hematology
Paola Guglielmelli, Daniela Pietra, Fabrizio Pane, et al.
Pulmonary Pharmacology & Therapeutics
|
September 15, 2019
Efficacy and cardiovascular safety profile of dual bronchodilation therapy in chronic obstructive pulmonary disease: A bidimensional comparative analysis across fixed-dose combinations
Paola Rogliani, Maria Gabriella Matera, Beatrice Ludovica Ritondo, et al.
Pulmonary Pharmacology & Therapeutics
|
May 5, 2004
Salmeterol/fluticasone propionate in a Single Inhaler Device versus theophylline+fluticasone propionate in patients with COPD
Mario Cazzola, Paolo Noschese, Stefano Centanni, et al.
Respiratory Medicine
|
August 9, 2008
It's about time--directing our attention toward modifying the course of COPD
Mario Cazzola, Nicola A Hanania, Paul W Jones, et al.
Page
of 65